South African biotech startup SX4 Genetics has raised a US$ 2.5 million Series A round from Alethea Capital.
3X4 Genetics, which launched in 2018, will channel the funds towards growth in the US market in 2020.
The Heavy Chef Foundation recently listed 3X4 Genetics among South Africa’s top five most exciting startups. The startup beat over 600 nominated startups for this listing in the country.
SX4 Genetics launched in mid 2018 after raising funds from angel investors in January 2018.
The company offers advanced nutrigenetic testing and translation provided by a network of trained and accredited practitioners to empower people to listen to their bodies and make sound, daily choices to live longer, healthier and better lives.
Related article: Ilaya Health raises $735k to grow operations in Kenya
It was founded in 2018 by Dr. Yael Joffe and Jason Haddock, scientist and behavioural specialist respectively.
Joffe said, “As society begins to increasingly look to technology to address their questions regarding their health, 3X4 Genetics combines science and technology to make the insights offered by genetic testing more accessible and relatable to the average person.”
“Every minute of every day we make decisions that affect our genes and, in turn, our health. If we really understand ourselves and our genes, we can understand the implications of every decision. By offering customers unique pathway-based genetic health insights, we’re in a position to help them make the best health choices,” adds Hoffe.
In turn Haddock said, “Our overarching goal is to help our ten million customers achieve their human health potential.”
3X4 Genetics has also created an ecosystem for healthcare practitioners in South Africa.
It’s educational platform offers a route for practitioners to become experts in translational genomics, making it possible for them to offer genetic testing as a value-add to their clients.
